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Lea M. Sommer1,2, Rasmus L. Marvig2,3, Adela Luján4, Anna Koza1, Tacjana Pressler5, Søren Molin1,6
and Helle K. Johansen1,2*
Abstract
Background: The primary cause of morbidity and mortality in cystic fibrosis (CF) patients is lung infection by
Pseudomonas aeruginosa. Therefore much work has been done to understand the adaptation and evolution of P.
aeruginosa in the CF lung. However, many of these studies have focused on longitudinally collected single isolates,
and only few have included cross-sectional analyses of entire P. aeruginosa populations in sputum samples. To date
only few studies have used the approach of metagenomic analysis for the purpose of investigating P. aeruginosa
populations in CF airways.
Results: We analysed five metagenomes together with longitudinally collected single isolates from four recently
chronically infected CF patients. With this approach we were able to link the clone type and the majority of SNP
profiles of the single isolates to that of the metagenome(s) for each individual patient.
Conclusion: Based on our analysis we find that when having access to comprehensive collections of longitudinal
single isolates it is possible to rediscover the genotypes of the single isolates in the metagenomic samples. This
suggests that information gained from genome sequencing of comprehensive collections of single isolates is
satisfactory for many investigations of adaptation and evolution of P. aeruginosa to the CF airways.
Keywords: Metagenomics, Longitudinal isolates, Pseudomonas aeruginosa, Cystic fibrosis
Background
Cystic fibrosis (CF) is a hereditary disease that causes
malfunction of a chloride channel affecting the viscosity of
the mucus on all muco-epithelial surfaces. Among other
things, this results in impaired clearance of bacteria and
other microorganisms from the airways with an associated
increased risk of lung infections [1]. CF is the most com-
mon life-limiting genetic disorder in Caucasians, and lung
infection with Pseudomonas aeruginosa is the primary
cause of morbidity and mortality in CF patients [2, 3]. In
the clinic, antibiotic treatment of these infections is usually
based on the assumption that the bacterial populations in
CF airways are homogeneous. In accordance with this as-
sumption, several studies of the adaptation of P. aeruginosa
to the CF airway environment with regard to e.g. resistance
development [4, 5], metabolism [6], escape from the im-
mune system [7], and transmission between niches in the
airways of a patient [8] and between patients [9, 10], have
primarily been carried out based on investigations of single
longitudinally stored bacterial isolates [11–13].
However, it was recently shown that long-term bacterial
infections of CF airways cannot solely be described as a
“dominant lineage” model, where the infecting clone type
adapts in a linear fashion, and new variants with increased
fitness quickly outcompete their less fit ancestors [14].
Because of the heterogeneous environment of the CF air-
ways, it is more likely a “diverse community” model that
best describes the bacterial populations of the CF airways.
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This is a consequence of adaptive radiation and the devel-
opment of different subpopulations with a high degree of
polymorphic mutations [11, 14–16].
Thus, the question is whether genomic information
from single isolates collected longitudinally from the same
patient is sufficient for the characterization of adaptive
and evolutionary processes in P. aeruginosa populations
in CF airways. To answer this question, we have compared
the sequences from longitudinally collected single isolates
with single metagenomes from four CF patients. There-
fore, rediscovery in the metagenomes of the genome se-
quences derived from the single isolates document that
they constitute a substantial sub-population and thus are
representative for the infecting population of the patient.
Methods
We included four CF patients followed at the CF clinic at
Rigshospitalet, Copenhagen, Denmark. The age of the
patients ranged from 15 to 31 years and they were all re-
cently diagnosed as chronically infected with P. aeruginosa
(Copenhagen criteria [17]).
Longitudinally collected single isolates
Genome sequenced longitudinally collected single isolates
from the patients are described in details in Marvig et al.
[13]. The single isolates included in this study cover P.
aeruginosa sampled from: endolaryngeal suction, sputum
samples, sinus samples taken at endoscopic sinus surgery,
swabs from the sinuses, and bronchoalveolar lavage (BAL).
Isolation and identification of P. aeruginosa from CF spu-
tum samples was carried out as previously described [13].
Metagenomic samples
Sputum samples were collected at the CF clinic at
Rigshospitalet and samples were processed a median of
2 days after expectoration (range: 1–3 days, Additional file
1: Table S1). During the lag-time between expectoration
and processing the samples were stored at 4 °C.
Processing of metagenomic samples
The samples were treated with ca. 1:1 (v/v) 10× diluted
Sputasol (Oxoid, c/o Thermo Fisher Scientific, UK)
with continuous vigorous shaking for 30 min. for
homogenisation.
The samples were divided into two fractions, one was
plated on Pseudomonas isolation agar (PIA) plates and in-
cubated in 24–72 h at 37 °C depending on when colonies
appeared and before single colonies could no longer be
picked. The single colonies were then grown in 96 well
microtitter plates with 150 μl Luria Broth (LB) for 24–48 h.
One hundred μl 50 % glycerol was added and the isolates
were stored at −80°. The other fraction was directly
subjected to DNA extraction (200–600 μl Sputasol
treated sample), or stored at −20 °C until batch DNA
purification could take place.
DNA extraction was carried out as in Lim et al. [18],
with slight modifications: β-mercapoethanol was replaced
by Sputasol treatment, centrifugation times were extended
to 20 min at 3800×g, the volumes were adjusted to: 1.5 ml
autoclaved milliQ, 100–200 μl DNase buffer and 3–6 μl
DNase (depending on pellet size), and 1.5 SE buffer, with
the Powersoil® DNA isolation kit (MO BIO Laboratories,
USA) used according to the manufacturer, for DNA
purification.
Sequencing and analysis of metagenomic reads
Libraries were prepared in triplicates with Nextera XT
Sample Preparation kit (Illumina Inc., USA) and pooled
prior to sequencing on an Illumina MiSeq® bench-top se-
quencer with MiSeq reagent kit V2, 300 cycles (Illumina
Inc., USA), resulting in 150 bp paired end reads. Initial
analysis of the reads (also used for species identification)
was carried out using Novoalign V2.07.18 (Novocraft
Technologies [19]) for alignment to a library of human
(GRCh37, ftp://ftp.ncbi.nlm.nih.gov/genomes/H_sapiens/
Assembled_chromosomes/seq/hs_ref_GRCh37.p13_chr*m-
fa.gz), bacterial, archaeal, viral, and fungal (The NCBI data-
base, downloaded: November 11th 2013) sequences. All
sequences aligning to the human genome were discarded.
The analysis of the P. aeruginosa population was per-
formed according to Marvig et al. [13]. This implies:
Alignment to the P. aeruginosa PAO1 reference genome
(GenBank accession NC_002516.2; genome size of 6.4 Mb)
with Bowtie 2 V2.0.2 [20] and The Genome Analysis Tool-
kit (GATK) V1.0.5083 [21] for realignment around indels.
This simultaneously removed all non-P. aeruginosa reads
from the metagenomic reads. The pileups of read align-
ments were performed with SAM tools V0.1.7 (r50) [22].
SNP calling from the metagenomic reads was carried out
by manually identifying positions where mutations had
previously been identified in the single isolates of the clone
types from the same patients as the analysed metagenomes.
The mutations of the single isolates have previously been
discussed and presented in Marvig et al. [13]. Raw de novo
assemblies of the metagenomes were carried out using
Velvet [23] (version 1.2.10) with a k-mer length of 33 and
the options set as follows: ‘-scaffolding no –ins_length 500
–cov_cutoff 3 –min_contig_lgth 500’. De novo-assembled
genomes were aligned against each other using MUMmer3
[24] (version 3.23).
Maximum likelihood phylogenetic analysis was carried
out with PAUP* [25] version 4.0b10 without root, using
the alleles identified by the single isolate sequencing. The
metagenomes were placed in the tree depending on their
major alleles at positions where polymorphisms occurred.
Maximum parsimonious phylogenetic analyses were also
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carried out with PAUP* version 4.0b10 using alleles of ref-
erence strain PAO1 as a root.
The rediscovery of SNPs from the single isolates in the
metagenomes were done based on the assumption that if
a SNP previously identified in the single isolates was
present in more than 10 % of the reads, this was a redis-
covered SNP. When looking at polymorphisms, only posi-
tions with a phred score >30 and with ≥4 read coverage
were considered. This was then compared to the overall
coverage of PAO1, to make the ratio presented in Fig. 6.
Diversity measurement by phylogenetic analysis of single
isolates
Diversity is shown as the mean distance to the Line
of Decent (LOD) [12]. LOD is the immediate line
from the root, here based on PAO1 as out-group, to
the latest sampled isolate (the red line in the phylo-
genetic trees in Fig. 5), and the mean distance to
LOD is the mean number of SNPs from this line to
the remaining isolates.
Diversity measurement of metagenomic samples
Polymorphic positions were identified as described
above. Because of the varying coverage of the different
samples, the polymorphisms found were compared to
the overall coverage of the PAO1 genome, and diversity
was calculated as a ratio of polymorphisms and cover-
age. The reason, for using polymorphisms as a diversity
measurement, was based on the assumption that the
more positions a population diverge in, the more diverse
is it likely to be.
As example: if we have e.g. two or three subpopula-
tions they will differ from each other in a number of
positions creating more ambiguous base calls and thus a
higher ratio of polymorphisms, than a single homoge-
neous population. However, it is not possible to
differentiate between two, three, or more different sub-
populations based on this method. This is because of the
possibility of a deep phylogenetic branching of two sub-
populations and a shallow branching of three or more
subpopulations.
Statistics
For comparisons of the rediscovery ratio of SNPs from
single isolates in metagenomes and comparisons of diver-
sity measurements of single isolates and metagenomes we
used Fisher’s Exact Test with Holm correction for mul-
tiple testing, in R [26].
Results
Patient information and P. aeruginosa infection patterns
Four CF patients were enrolled in this study, median age
24 years; range 15–31, at the time of metagenome sam-
pling. From each of the patients we have previously genome
sequenced 9 to 27 longitudinally collected P. aeruginosa
isolates covering 1–7 years of infection [13]. From the four
patients we collected either one (n = 3) or two (n = 1)
sputum samples for metagenomic analysis (Fig. 1a).
a
b
Fig. 1 Overview. a Overview of single isolate sampling from four CF patients, clone types that are considered to be transient (found in 1–2 time
points) are marked with #, +, x, or *, whereas clones considered to be persistent in the patient is marked by coloured circles. Metagenomes are
marked with stars, black if sampled before i.v. antibiotic treatment, and white if sampled after i.v. antibiotic treatment. b Overview of metagenome
sampling from patients, in correlation with 2-week i.v. antibiotic treatment
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Accordingly, sputum samples S1, S2, and S3 were sampled
from patients P41M3, P99F4, and P92F3, respectively, and
sputum samples S4a and S4b, separated by two weeks,
were sampled from patient P82M3. The sputum samples
used for the metagenome sequencing were collected
approximately 1 year after the most recently genome
sequenced single isolate. The time period between the
most recently genome sequenced isolate and the
metagenome is not critical, since the main question
addressed here is whether or not the genotypes of the
single isolates can be rediscovered in the metage-
nomic samples.
Three of the four patients (P41M3, P92F3, and
P82M3) have infection patterns that are characteristic
for the majority of the P. aeruginosa infected CF patients
at the Copenhagen CF Center at Rigshospitalet [27],
with a single primary clone type in the entire collection
period. One patient (P99F4) has a change in clone type,
where one clone type was outcompeted by another
(Fig. 1a). All four patients in this study were recently
diagnosed as chronically infected with P. aeruginosa
according to the Copenhagen definitions at the time of
metagenome sampling [17].
Processing of sputum sample reads
The metagenome sequences were aligned to a database
containing all bacterial, fungal, and viral genome se-
quences deposited at NCBI (see Methods). With a me-
dian of 96 % of all bacterial reads (Additional file 2:
Table S2), P. aeruginosa was the dominating microbial
species in the patients, corresponding to their clinical
diagnosis as chronically infected with P. aeruginosa. We
further aligned reads from the sputum metagenomes to
the P. aeruginosa PAO1 reference genome, as we have
previously done for the single isolates [13]. In all cases,
the metagenomes had an average coverage of 5.99 Mbp
(range: 5.90–6.04 Mbp) of the 6.3 Mbp PAO1 reference
genome, by >3 reads and a phred score >30 (Additional
file 3: Table S3). This high genomic coverage ensured
that the presence or absence of polymorphisms in the
metagenomes could be determined at the majority of
genomic positions. On average, sequenced positions
were covered by 10 to 31 reads giving us the opportunity
to identify subpopulations that are present in more than
10 % of the population at the positions with the lowest
coverage (Additional file 3: Table S3).
In order to compare the P. aeruginosa population
structure and diversity as displayed by the single isolates
and the compliance with the metagenomic read
assemblies, we conducted a three step analysis: 1) Identi-
fication of the dominant clone type(s) in the sputum
samples, 2) investigation if mutations in the genomes of
the single isolates were also identified in the
metagenomes, i.e. rediscovery of SNPs in the meta-
genomes, and 3) comparison of diversity measure-
ments of the populations represented by the single
isolates and the metagenomes.
Identification of the dominant clone type(s)
To identify the P. aeruginosa clone types represented
in the metagenomes, de novo assemblies of single iso-
lates and metagenomes were compared. For each pa-
tient the clone types represented by the single isolates
were compared with the metagenome(s) from the
same patient.
For all four patients, the clone type of the most re-
cently sampled single isolate corresponded to the clone
type identified from the metagenome with less than 528
SNP of differences (median 131 SNPs, range 91–527
SNPs). In contrast, when comparing the metagenomes
with single isolates of other clone types they differed by
more than 16,268 SNPs (median 17,844 SNPs, range
16,269–30,918 SNPs) (Additional file 4: Table S4A and
Table S4B).
This shows that for each patient the most recent
clone type identified by the genome of the single iso-
late matches the dominating clone type in the P. aer-
uginosa population identified in the sputum sample
metagenome.
Rediscovery of SNPs in the metagenomes
Previous investigations of genome evolution in the clonal
lineages of P. aeruginosa strains from each of the four
patients [13] identified SNPs accumulating in the clonal
populations. If these SNPs are indeed present in actual
propagating lineages of the P. aeruginosa population of
these patients, they should also be present in the metagen-
ome(s). When looking at all the SNPs identified in all the
single isolates, it is expected that the ratio of rediscovery
of SNPs between single isolates and metagenomes from
the same patients should exceed the ratio determined be-
tween single isolates and metagenomes of different pa-
tients. Further, this ratio should reach a value of one if all
mutations found in the single isolates are also present in
the metagenome.
With the exception of patient P99F4 and P92F3, who are
infected with the same clone type (DK26), the rediscovery
of SNPs from the single isolates in the metagenome(s) of
the same patient was found to be significantly higher than
between patients (Fig. 2, p <0.05, Fisher’s exact test with
Holm correction). This supports the specific linkage be-
tween single isolates and the P. aeruginosa population as a
whole, as hypothesised above.
In one case (S2 from P99F4), the ratio of the rediscovery
of SNPs reached one, suggesting that all SNPs identified
in the single isolates are present in more than 10 % of the
whole population. In all other cases the ratio was below
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one, which could be due to 1) not all mutations being
fixed in the population, i.e. they were lost during the time
of sampling of the single isolates (harbouring the muta-
tions) until sampling of the metagenome, or 2) some of
the mutations being present in only a small fraction
(<10 %) of the population and therefore not sampled by
the metagenomic reads. In the case of P92F3 the SNPs
that were not rediscovered were only present in 11–22 %
(Additional file 5: Table S5) of the single isolates, and thus
could be explained by mutations not being fixed in the
population.
The metagenomes S4a and S4b from patient P82M3
illustrate both explanations above: Firstly, the much
lower ratio of rediscovery of SNPs in patient P82M3
compared to the other patients, may be explained by
the presence of hypermutators in the P. aeruginosa
population of P82M3. Hypermutators are known to
accumulate many unfavourable mutations [28], which
are not expected to remain in the population, thus
leading to a low ratio of rediscovery (assuming that
the mutations are not hitch-hiking with more
favourable mutations). Secondly, the low coverage of
the metagenomic samples (Additional file 3: Table S3)
resulted in a higher percentage of the SNPs being
rediscovered in the later metagenome (S4b) than in
the early metagenome (S4a). The rediscovery of SNPs
in the two metagenomes correspond to 26 % (122 of
461) and 12 % (54 of 461), respectively (Additional
file 5: Table S5). This is contradictory since the muta-
tions were previously identified in the single isolates
and therefore must be present to some degree in S4a
in order to be identified in S4b. This suggests that
the subpopulation represented by the S4b metagen-
ome is present below the limit of detection in the
S4a metagenome sequences and is therefore not
identified.
For patients P99F4 and P92F3 the similar rediscovery
ratios of SNPs between the metagenomes and the single
isolates can be explained by a co-infection of the same
clone type, DK26. This relationship was noted previously
and seems to be the consequence of a patient-to-patient
transmission event of the DK26 clone from P92F3 to
P99F4 [13], explaining the lack of differentiation be-
tween the two P. aeruginosa populations. However, des-
pite this close relationship between the populations,
Fig. 3 shows that it is possible to distinguish between
the SNPs of the single isolates and the respective
metagenomes.
We have identified SNPs in genome sequences of lon-
gitudinal single isolates, which seem to be characteristic
and representative for the patient community, including
cases of infections caused by patient-to-patient transmit-
ted clones. This patient specific relationship between
metagenomes and single isolates is further documented
by the phylogenetic analysis of the single isolates and
metagenomes of the hypermutator population of patient
P82M3 (Fig. 4), which shows that despite the highly in-
creased mutation rate, the metagenomes are placed
within the phylogeny of the single isolates from the pa-
tient (Fig. 4). This phylogeny also shows that the single
isolates are not clustered depending on their origin of
sampling, indicating that the population is mixed be-
tween the upper and lower airways and that the different
subpopulations are not limited to a specific spatial pos-
ition in the airways.
Diversity of the P. aeruginosa populations
In the single isolates, the diversity of the P. aeruginosa
populations was determined from the phylogenies as the
mean distance to the Line of Decent (LOD) (Fig. 5). For
the metagenome-estimated diversity (Fig. 6) we used the
number of polymorphisms normalised to the number of
Fig. 2 SNP rediscovery in metagenomes. Above each subfigure it is indicated which single isolates’ SNPs that have been sought rediscovered in
the metagenomes (clone type and patient). The grey bars indicate the ratio of SNP positions that were sequenced in the metagenomes and the
black bars indicate the ratio of the rediscovered reads to the sequenced positions. The metagenome(s) belonging to the same patient as the single
isolates they are compared to is indicated with a larger font. NOTE, S2 and S3 are from different patients but the same clone type. P <0.05, Fisher’s
exact test with Holm correction, significant differences are indicated by “a” and/or “b”
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positions covered in the PAO1 genome in order to correct
for differences in coverage between the different metagen-
omes (see Methods for details). Because S4a and S4b
(patient P82M3) are representative of the same population
we chose to merge the samples to carry out the inter-
patient comparison of diversity (Fig. 6: “S4, avg.”). In both
the LOD calculations and the number of polymorphisms
we find, that the hypermutator population of patient
P82M3 had the highest diversity and that the patient with
the shortest period of infection (P92F3), as expected, har-
boured the least diverse population, to some degree valid-
ating our method of diversity calculations. We calculated
34.89 and 1.33 mean distances to LOD for the two single
isolate populations, and diversity ratios of 7.08E-05, and
4.20E-05 for the metagenome populations from the two
patients P82M3 and P92F3, respectively. Thus, in both
cases of diversity measurements both single isolates and
metagenomes we saw a significant difference between the
diversity of the P. aeruginosa populations of patient
P82M3 and P92F3 (p <0.05, Fisher’s Exact test with Holm
correction) (Figs. 5 and 6).
When analysing further the single population of patient
P82M3, the diversity calculations for the samples S4a and
S4b illustrate that exhaustive sampling is essential, not only
when using single isolates but also for metagenomic
samples, in order to get the true picture of the population
diversity. Because these two metagenomes represent a
non-mutator and a hyper-mutator subpopulation, resp-
ectively, they have significantly different diversity ratios
(4.90E-05 and 9.25E-05, respectively, p <0.05 Fisher’s Exact
test with Holm correction).
Discussion
Airway infection in CF patients has attracted consider-
able interest as a model system for bacterial evolution
and long-term human infections [29]. There is a number
of reasons for this interest: 1) The infections are often
mono-clonal lasting for decades, which can correspond
to more than 100,000 bacterial generations [30], 2) sam-
pling from the patients is relatively simple (sputum,
BAL, suction), 3) the environmental conditions in the
patient airways are very similar, and 4) isolate collections
are found in many CF clinics covering long periods of
sampling time. Several investigations of long-term CF
airway infections based on the analysis of longitudinally
collected single isolates of P. aeruginosa have been pub-
lished in recent years [5, 6, 12, 13, 30–32], and some
have also included cross-sectional analyses of the popu-
lation diversity at the genomic level [11, 16, 33, 34]. One
reason to question the validity of using single isolates to
Fig. 3 Patient specific correlation of rediscovered SNPs within a single clone type. A comparison of the SNPs found in the single isolates of the
patients P99F4 and P92F3 as well as their respective metagenomes, S2 and S3. For the single isolates a dark green colour indicates the presence
of SNPs and white the absence. For the metagenomes the percentage of reads covering the position of a SNP is indicated by dark green (>90 %),
light green (51-90 %), or white (11-50 %) all considered to confirm the presence of the SNP in question. If the SNP is only found in <=10 % of the
reads it is indicated by grey and not considered to be present in the metagenome(s)
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infer evolutionary dynamics of the entire population is
the apparent heterogeneity of the P. aeruginosa popula-
tion in the CF patients [11, 15, 16, 33–36].
In this study we have compared five meta-genomes
obtained from four CF patient sputum samples with cor-
responding single, longitudinally collected, P. aeruginosa
isolates, and a high degree of correlation was found
within populations. The metagenomes were sampled
from patients with the most common P. aeruginosa
infection pattern, continuous culture of the same clone
type, at the Copenhagen CF Centre [27], and they are
therefore assumed to be representative for most of the
CF patients and their lung infection. The collection of P.
aeruginosa isolates from CF patients associated with the
Copenhagen CF Clinic is comprehensive and character-
ized by frequent longitudinal sampling from the patients
and frequent replicate isolates from individual patient
samples. These features make the collection unique and
useful for an assessment of the validity of single isolate
analysis in relation to both biological and medical
aspects. In general, single isolates and metagenome
analyses depend on exhaustive sampling. Due to the pos-
sibility of temporal dominance by different subpopula-
tions, as seen by the hyper-mutator population of
P82M3, the metagenomic approach will also require
multiple samples to reveal the profile and dynamics
of P. aerugonosa populations. The results of this
study, taken together with similar results from other
studies [12], suggest that using comprehensive collec-
tions of longitudinally collected single isolates in the
research of adaptation and evolution of P. aeruginosa
to the CF airways will yield conclusive results.
One limitation of our study compared to e.g. that of
Lieberman et al. [14] is the sequencing depth. This is es-
pecially true for the highly diverse population of P82M3,
in which we were unable to identify subpopulations if
present in less than 10 % of the population (the lowest
coverage is 9.97). However, despite the lower sequencing
depth, we were able to document a high degree of diver-
sification of the populations in analogy with findings
from Lieberman [14] and others [15, 16, 33]. In addition,
we were also able to determine that the different sub-
populations comprising this diversity differ in frequency
over time. Especially in the hyper-mutator population,
we noticed that the bacterial population is dominated by
different subpopulations at different time points (Table 1
and Fig. 4).
Population diversity was not the primary target of the
investigations reported here due to the relatively short
time frame of sampling and the resulting low number of
mutations in the respective isolate genomes. However, the
two cases of hyper-mutator isolates suggest that diversity
is prevalent, resulting in significant population heterogen-
eity. This heterogeneity may be the result of spatial com-
partmentalisation of the CF airways and the confinement
of different subpopulations to different niches [11, 35].
One obvious example of compartmentalization of the CF
airways is illustrated by bacterial infections in both lungs
and sinuses. Spatial isolation and adaptive radiation of
different subpopulations in these niches has been sug-
gested by Markussen [11] and Hansen [35]. In contrast,
our current findings from longitudinally collected P.
aeruginosa from upper and lower airways in younger CF
patients [13] do not confirm this; instead, in accordance
with Ciofu [37] and Johansen [38] we find that bacterial
Fig. 4 DK32 P82M3 maximum likelihood phylogeny including
metagenomes. Blue shapes indicate single isolates sampled with
different methods and from different locations (see legend) and
stars indicate metagenomes. The scale bar indicates 0.1 likelihood
of mutation
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migration in both directions and consequential population
mixing occurs between the upper and lower airways after
a certain period of chronic infection (Fig. 4). Mixing of
bacterial populations colonizing different airway compart-
ments is also supported by other studies showing both
genotypic and phenotypic overlap between samples from
the upper and lower CF airways [37, 39].
Population mixing in CF airways is supported by
frequent observations of clone type displacement;
both in investigations of older CF patients with
chronic P. aeruginosa lung infections [10] and in
young patients with early colonization by P. aerugi-
nosa. These findings are difficult to reconcile with
spatial isolation and adaptive radiation, whether distri-
bution of sub-populations is associated with the lung/
sinus compartments or different sectors of the lungs
as reported recently [40]. It is possible that the
infections in fact switch between periods of adaptive
radiation and spatial isolation of sub-populations
resulting in diversity generation and periods of mixing
caused by lung tissue changes. Such changes in popu-
lation dynamics could explain the conflicting observa-
tions as well as the slow replacement of clone types,
which sometimes take months or even years.
Conclusions
We find a consistency between the genomic changes
identified in the single isolates and in the metagenomes,
which can only be explained by the propagation of
mutations identified by the analysis of single isolates
within the specific patient’s P. aeruginosa population.
These findings underline the relevance of comprehensive
longitudinal sampling of single isolates of P. aeruginosa
for investigations of adaptation and evolution. We also
find it equally important for the metagnomic approach to
Fig. 5 Mean distance to Line of Decent (LOD). Maximum parsimonious phylogenetic trees for all clone types identified in the metagenomes as
being the latest. The red line in the trees indicates the LOD wherefrom SNPs (numbers on branches) have been counted. The LOD is set from the
root (created for P41M3 and P82M3 using PAO1 as out-group) to the divergence of latest sampled isolates. White circles indicate the earliest sampled
isolates and black circles indicates the latest sampled isolates from each patient, the coloured circles are comparable to the colours of Fig. 1. For each
patient a mean distance to LOD is indicated below the patient name to the right of the corresponding tree. The mean distance to LOD of P82M3 is
significantly different from the other patients, p <0.01, Fisher’s Exact test with Holm correction
Fig. 6 Polymorphic positions in the metagenomes. Because of the
differing coverage of the PAO1 reference genome, the number of
polymorphisms is shown as a ratio of polymorphisms and the
coverage of each metagenome to PAO1. S4, avg. is the average of
S4a and S4b. p <0.05 Fisher’s exact test with Holm correction
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have comprehensive sampling, in order to provide
valuable information about the P. aeruginosa population
dynamics of CF patient airway infections. It is, however
important to emphasise that the conclusions to be drawn
from this type of investigation will not provide a complete
picture of the population diversity in the respective
samples.
Additional files
Additional file 1: Table S1. Sampling information of metagenomes.
(XLSX 36 kb)
Additional file 2: Table S2. Species ratios in metagenomes. All species
presented have been detected in >0.5 % of the bacterial reads of at least
one metagenomic sample, if a species is detected with <0.01 % it is
shown here as 0.00 %. (XLSX 47 kb)
Additional file 3: Table S3. Coverage of PAO1 by the metagenomes,
coverage with >3 reads per position and phred score >30. (XLSX 37 kb)
Additional file 4: Table S4A. Isolate and metagenome information of
clone type (for the metagenomes this is the clone type that is supposed
to be dominating, assumed from the single isolate information of the
given patient). Table S4B: Genome comparisons of single isolates and
metagenomes. (XLSX 42 kb)
Additional file 5: Table S5. Detailed overview of SNPs found in
single isolates and the rediscovery in the metagenomic reads. For
each isolate it is indicated whether the mutation has been discovered
or not, indicated by 1 and 0 respectively. For each metagenome the
percentage of reads (%) representing the SNP found in the single
isolates are shown together with the actual number of reads that have
been called for each base, C, G, A, and T. For the metagenome(s) it is
indicated at the bottom of the column the number of SNPs
rediscovered in >10, 50 and 90 % of the metagenomic reads, as well
as the total number of SNPs covered by the metagenomic reads.
(XLSX 239 kb)
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Table 1 SNPs rediscovered in S4a and S4b
Total no. of reads on position % of reads with the mutation
Position Ref Qry Mutation (aa) Mutation (bp) PA no. Gene name S4a S4b S4a S4b
5671 C T S466F C1397T PA0004 gyrB 15 13 7 100
2453983 G A G106D G317A PA2231 pslA 17 17 24 0
2640133 A G F43L T127C PA2386 pvdA 15 12 0 100
2926243 C G E64Q G190C PA2586 gacA 5 11 0 100
3970113 G A G172A G58S PA3545 algG 15 11 87 0
3971271 G A G1330A G444S PA3545 algG 19 13 0 100
5551035 A C V216G T647G PA4946 mutL 11 8 9 100
5677066 T C T265A A793G PA5040 pilQ 12 17 17 100
6028514 G A E325K G973A PA5361 phoR 5 12 100 0
Including examples of mutations not found in S4a but found in S4b (Ref reference base, Qry query base, PA no. PAO1 gene number, aa amino acid change, bp
specific base pair substitution). NOTE: all mutation types are missense mutations
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